These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 33981312)

  • 21. Putative mechanism of neurological damage in COVID-19 infection.
    Bandala C; Cortes-Altamirano JL; Reyes-Long S; Lara-Padilla E; Ilizaliturri-Flores I; Alfaro-Rodríguez A
    Acta Neurobiol Exp (Wars); 2021; 81(1):69-79. PubMed ID: 33949163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does COVID-19 contribute to development of neurological disease?
    Mahalakshmi AM; Ray B; Tuladhar S; Bhat A; Paneyala S; Patteswari D; Sakharkar MK; Hamdan H; Ojcius DM; Bolla SR; Essa MM; Chidambaram SB; Qoronfleh MW
    Immun Inflamm Dis; 2021 Mar; 9(1):48-58. PubMed ID: 33332737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The neurology of COVID-19].
    Cuevas-García C; Calderón-Vallejo A; Berrón-Ruiz L
    Rev Alerg Mex; 2020; 67(4):338-349. PubMed ID: 33631902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurological infection with SARS-CoV-2 - the story so far.
    Solomon T
    Nat Rev Neurol; 2021 Feb; 17(2):65-66. PubMed ID: 33414554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CNS implications of COVID-19: a comprehensive review.
    Nagu P; Parashar A; Behl T; Mehta V
    Rev Neurosci; 2021 Feb; 32(2):219-234. PubMed ID: 33550782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut-brain communication in COVID-19: molecular mechanisms, mediators, biomarkers, and therapeutics.
    Wais T; Hasan M; Rai V; Agrawal DK
    Expert Rev Clin Immunol; 2022 Sep; 18(9):947-960. PubMed ID: 35868344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients.
    Giron LB; Dweep H; Yin X; Wang H; Damra M; Goldman AR; Gorman N; Palmer CS; Tang HY; Shaikh MW; Forsyth CB; Balk RA; Zilberstein NF; Liu Q; Kossenkov A; Keshavarzian A; Landay A; Abdel-Mohsen M
    Front Immunol; 2021; 12():686240. PubMed ID: 34177935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 and Neurological Impairment: Hypothalamic Circuits and Beyond.
    Mussa BM; Srivastava A; Verberne AJM
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33802995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurological Complications Associated with the Blood-Brain Barrier Damage Induced by the Inflammatory Response During SARS-CoV-2 Infection.
    Alquisiras-Burgos I; Peralta-Arrieta I; Alonso-Palomares LA; Zacapala-Gómez AE; Salmerón-Bárcenas EG; Aguilera P
    Mol Neurobiol; 2021 Feb; 58(2):520-535. PubMed ID: 32978729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurological pathophysiology of SARS-CoV-2 and pandemic potential RNA viruses: a comparative analysis.
    Chakravarty N; Senthilnathan T; Paiola S; Gyani P; Castillo Cario S; Urena E; Jeysankar A; Jeysankar P; Ignatius Irudayam J; Natesan Subramanian S; Lavretsky H; Joshi S; Garcia G; Ramaiah A; Arumugaswami V
    FEBS Lett; 2021 Dec; 595(23):2854-2871. PubMed ID: 34757622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 and the gastrointestinal tract: Source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection?
    Troisi J; Venutolo G; Pujolassos Tanyà M; Delli Carri M; Landolfi A; Fasano A
    World J Gastroenterol; 2021 Apr; 27(14):1406-1418. PubMed ID: 33911464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Effect of Bacterial Infections, Probiotics and Zonulin on Intestinal Barrier Integrity.
    Serek P; Oleksy-Wawrzyniak M
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222).
    Román GC; Gracia F; Torres A; Palacios A; Gracia K; Harris D
    Front Immunol; 2021; 12():653786. PubMed ID: 33981305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurological Complications in COVID-19 Patients and its Implications for Associated Mortality.
    AboTaleb HA
    Curr Neurovasc Res; 2020; 17(4):522-530. PubMed ID: 32718292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurological manifestations of COVID-19: A brief review.
    Sachdev K; Agrawal S; Ish P; Gupta N; Raheja K
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):41-47. PubMed ID: 32859864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurotropic Effects of SARS-CoV-2 Modeled by the Human Brain Organoids.
    Ramani A; Pranty AI; Gopalakrishnan J
    Stem Cell Reports; 2021 Mar; 16(3):373-384. PubMed ID: 33631123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neurological aspects of the COVID-19 pandemic caused by the SARS-CoV-2 coronavirus].
    Bereczki D; Stang R; Böjti P; Kovács T
    Ideggyogy Sz; 2020 May; 73(05-06):171-175. PubMed ID: 32579306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-Grade Endotoxemia and Thrombosis in COVID-19.
    Oliva A; Cammisotto V; Cangemi R; Ferro D; Miele MC; De Angelis M; Cancelli F; Pignatelli P; Venditti M; Pugliese F; Mastroianni CM; Violi F
    Clin Transl Gastroenterol; 2021 Jun; 12(6):e00348. PubMed ID: 34092777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastrointestinal manifestations and nutritional therapy during COVID-19 pandemic: a practical guide for pediatricians.
    Oba J; Carvalho WB; Silva CA; Delgado AF
    Einstein (Sao Paulo); 2020; 18():eRW5774. PubMed ID: 32667418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract.
    Galanopoulos M; Gkeros F; Doukatas A; Karianakis G; Pontas C; Tsoukalas N; Viazis N; Liatsos C; Mantzaris GJ
    World J Gastroenterol; 2020 Aug; 26(31):4579-4588. PubMed ID: 32884218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.